In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats

Synapse

Volumn 32, Issue 4, 1999, Pages 254-261

  Richter, Regina M ^a,b   Weiss, Friedbert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

Amygdala; Cocaine; Corticotropin releasing factor; Microdialysis; Self administration; Withdrawal

Indexed keywords

ALCOHOL; COCAINE; CORTICOTROPIN RELEASING FACTOR; OPIATE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG SELF ADMINISTRATION; DRUG WITHDRAWAL; HORMONE RELEASE; IN VIVO STUDY; MALE; MICRODIALYSIS; NEUROENDOCRINOLOGY; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; WITHDRAWAL SYNDROME;

AMYGDALA; ANIMALS; COCAINE; CORTICOTROPIN-RELEASING HORMONE; MALE; NARCOTICS; RATS; RATS, WISTAR; SELF ADMINISTRATION; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0033563987     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19990615)32:4<254::AID-SYN2>3.0.CO;2-H     Document Type: Article

References (41)

1. Ambrosio E, Sharpe LG, Pilotte NS. 1997. Regional binding to corticotropin-releasing factor receptors in brain of rats exposed to chronic cocaine and cocaine withdrawal. Synapse 25:272-276.
2. Basso AM, Spina M, Rivier J, Vale W, Koob GF. 1999. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (in press)
3. Caine SB, Lintz R, Koob GF. 1993. Intravenous drug self-administration techniques in animals. In: Saghal A, editor. Behavioral neuroscience: a practical approach. Oxford: Oxford University Press. p 117-143.
4. Cassell MD, Gray TS. 1989. Morphology of peptide-immunoreactive neurons in the rat central nucleus of amygdala. J Comp Neurol 281:320-333.
5. Davis M. 1992. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 15:353-375.
6. de Fonseca RF, Carrera MRA, Navarro M, Koob GF, Weiss F. 1997. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 267:2050-2054.
7. Dunn AJ, Berridge CW. 1990. Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 15:71-100.
8. Ellinwood EH, Petrie WM. 1977. Dependence on amphetamine, cocaine and other stimulants. In: Pradan SN, editor. Drug abuse: clinical and basic aspects. St. Louis: Mosby. p 248-261.
9. Gardi J, Biro E, Sarnyai Z, Vecsernyes M, Julesz J, Telegdy G. 1997. Time-dependent alterations in corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration to rats. Neuropeptides 31:115-118.
10. Gawin FH, Ellinwood EH Jr. 1988. Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med 318:1173-1182.
11. Gawin FH, Kleber HD. 1986. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107-113.
12. Gray TS. 1993. Amygdaloid CRF pathways. Role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci 697:53-60.
13. Heinrichs SC, Pich EM, Miczek K, Britton KT, Koob GF. 1992. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic actions. Brain Res 581:190-197.
14. Heinrichs SC, Menzaghi F, Schulteis S, Koob GF, Stinus L. 1995. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol 6:74-80.
15. Hemby SE, Co C, Koves TR, Smith JE, Dworkin SI. 1997. Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat. Psychopharmacology 133:7-16.
16. Iwata J, Chida K, Le Doux JE. 1987. Cardiovascular responses elicited by stimulation of neurons in the central amygdaloid nucleus in awake but not anesthetized rats resemble conditioned emotional responses. Brain Res 418:183-188.
17. Koob GF. 1996. Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16:893-896.
18. Koob GF, Bloom FE. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
19. Koob GF, Markou A, Weiss F, Schulteis G. 1993. Opponent process and drug dependence: neurobiological mechanisms. Semin Neurosci 5:351-358.
20. Koob GF, Heinrichs SC, Menzaghi F, Pich EM, Britton KT. 1994. Corticotropin releasing factor, stress and behavior. Semin Neurosci 6:221-229.
21. Liang KC, Melia KR, Campeau S, Falls WA, Miserendino MJ, Davis M. 1992. Lesions of the central nucleus of the amygdala but not the paraventricular nucleus of the hypothalamus, block the excitatory effects of corticotropin-releasing factor on the acoustic startle reflex. J Neurosci 12:2313-2320.
22. Macey DJ, Basso AM, Rivier J, Vale W, Koob GF, Markou A. 1997. Corticotropin releasing factor (CRF) decreases brain stimulation reward in the rat. Soc Neurosci Abstr 23:521.
23. Markou A, Koob GF. 1991. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4:17-26.
24. Merlo Pich E, Koob GF, Heilig M, Menzaghi F, Vale W, Weiss F. 1993. Corticotropin-releasing factor release from the mediobasal hypothalamus of the rat as measured by microdialysis. Neuroscience 55:695-707.
25. Merlo Pich E, Lorang M, Yeganeh M, DeFonseca FR, Raber J, Koob GF, Weiss F. 1995. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15:5439-5447.
26. Parsons LH, Koob GF, Weiss F. 1995. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol Exp Ther 247:1182-1191.
27. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
28. Petrovich GD Swanson LW. 1997. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res 763:247-254.
29. Rassnick S, Heinrichs SC, Britton KT, Koob GF. 1993. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25-32.
30. Richter RM, Pich EM, Koob GF, Weiss F. 1995. Sensitization of cocaine-stimulated increase in extracellular levels of corticotropin-releasing factor from the rat amygdala after repeated administration as determined by intracranial microdialysis. Neurosci Lett 187:169-172.
31. Sakana M, Shibasaki T, Lederis K. 1987. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase diaminobenzidine method. J Comp Neurol 260:256-298.
32. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. 1993. Alterations of corticotropin-releasing factor-like immunoreactivity in different brain regions after acute cocaine administration in rats. Brain Res 616:315-319.
33. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. 1995. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res 675:89-97.
34. Smith JE, Co C, Freeman ME, Lane JD. 1982. Brain neurotransmitter turnover correlated with morphine-seeking behavior in rats. Pharmacol Biochem Behav 16:509-519.
35. Swanson LW, Sawchenko PE, Rivier J, Wale WW. 1983. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165-186.
36. Swiergiel AH, Takahashi LH, Kalin NH. 1993. Attenuation of stress-induced behavior by antagonism of corticotropin-releasing factor receptors in the central amygdala in the rat. Brain Res 623:229-234.
37. Vale W, Vaugham J, Yamamoto G, Bruhn T, Douglas T, Dalton D, Rivier C, Rivier J. 1983. Assay of corticotropin releasing factor. Methods Enzymol 193:565-577.
38. Weddington WW, Brown BS, Haertzen CA, Cone EJ, Dax EM, Herning RI, Michaelson BS. 1990. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psychiatry 47:861-868.
39. Weiss F, Markou A, Lorang MT, Koob GF. 1992. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res 593:314-318.
40. Wise RA. 1996. Neurobiology of addiction. Curr Opin Neurobiol 6:243-251.
41. Zhou Y, Spangler R, LaForge KS, Maggos CE, Ho A, Kreek MJ. 1996. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal. J Pharmacol Exp Ther 279:351-358.